Neuroglobin over expressing mice: expression pattern and effect on brain ischemic infarct size.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Stroke remains a leading cause of death and disability with limited therapeutic options.
• Neuroglobin, a neuronal heme-globin, shows potential as a therapeutic target for stroke and neurodegenerative diseases due to its cytoprotective effects.
• Understanding Neuroglobin's role requires detailed anatomical characterization and functional studies in relevant models.

Purpose of the Study:

• To anatomically characterize Neuroglobin overexpression in transgenic mice.
• To investigate the neuroprotective effects of elevated Neuroglobin on ischemic brain damage.
• To assess the influence of genetic background on stroke outcomes.

Main Methods:

• Generation and characterization of transgenic mice overexpressing Neuroglobin using validated antibodies and oligos.
• Induction of ischemic stroke via permanent middle cerebral artery occlusion (MCAO).
• Assessment of infarct volume, Neuroglobin expression (mRNA and protein) via immunohistochemistry and in situ hybridization, and analysis of genetic background effects.

Main Results:

• Transgenic mice exhibited a 4-5 fold increase in Neuroglobin mRNA and protein, primarily in cortical, hippocampal, and cerebellar neurons.
• Neuroglobin overexpression significantly reduced infarct volume 24 hours post-ischemia.
• Significant variations in infarct volume were observed between different colonies of the same mouse strain, indicating genetic background influence.

Conclusions:

• Neuroglobin overexpression is neuron-specific and regionally confined, contrary to some previous assumptions.
• A correlation between reduced infarct volume and elevated Neuroglobin levels is confirmed, necessitating further study of compensatory mechanisms.
• Genetic background significantly influences stroke outcomes, emphasizing the need for careful control of mouse strains and colonies in research.